Vermonters can take part in a clinical study of a possible vaccine against Lyme disease
Burlington Free Press
Vermont has a real problem with Lyme disease, with the second highest 3-year average incidence rate for the disease in the United States, according to Vermont Lyme, an organization that researches Lyme infections in the state.
To make matters worse, there's no vaccine for Lyme disease, although one might be on the way. The University of Vermont Medical Center and the Vaccine Testing Center at UVM's Larner College of Medicine will take part in a worldwide Phase 3 clinical study to investigate the efficacy and safety of an investigational Lyme disease vaccine candidate.
The study, known as the Vaccine Against Lyme for Outdoor Recreationists (VALOR) is sponsored by Pfizer, and is enrolling participants five years old and older.